Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA

doi:10.1016/j.medj.2021.04.010

. 2021 May 14;2(5):456-459.

doi: 10.1016/j.medj.2021.04.010.

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA

Kaveeta P Vasisht¹, Bridget M Nugent², Janet Woodcock³

Affiliations

¹ Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: kaveeta.vasisht@fda.hhs.gov.
² Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: bridget.nugent@fda.hhs.gov.
³ Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

PMID: 35590224
DOI: 10.1016/j.medj.2021.04.010

Free article

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA

Kaveeta P Vasisht et al. Med. 2021.

Free article

. 2021 May 14;2(5):456-459.

doi: 10.1016/j.medj.2021.04.010.

Authors

Kaveeta P Vasisht¹, Bridget M Nugent², Janet Woodcock³

Affiliations

¹ Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: kaveeta.vasisht@fda.hhs.gov.
² Office of Women's Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: bridget.nugent@fda.hhs.gov.
³ Office of the Commissioner, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

PMID: 35590224
DOI: 10.1016/j.medj.2021.04.010

Abstract

Recruiting and retaining diverse populations in clinical research is critically important. Over the years, we have seen improvements in the representation of women in clinical trials submitted in FDA marketing applications, and we are encouraged by the potential for new strategies to further their representation.

Published by Elsevier Inc.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no conflicts of interest. The contents of this publication reflect the thoughts of the authors and do not represent the official views of, nor an endorsement by, the FDA, Department of Health and Human Services, or US government.

Cited by

Leveraging Digital Health to Improve the Cardiovascular Health of Women.
Azizi Z, Adedinsewo D, Rodriguez F, Lewey J, Merchant RM, Brewer LC. Azizi Z, et al. Curr Cardiovasc Risk Rep. 2023;17(11):205-214. doi: 10.1007/s12170-023-00728-z. Epub 2023 Sep 30. Curr Cardiovasc Risk Rep. 2023. PMID: 37868625 Free PMC article. Review.
Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research.
Broadwin C, Azizi Z, Rodriguez F. Broadwin C, et al. Cardiol Ther. 2023 Jun;12(2):215-225. doi: 10.1007/s40119-023-00311-y. Epub 2023 Apr 12. Cardiol Ther. 2023. PMID: 37043079 Free PMC article.
Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure.
Hudson RE, Metz TD, Ward RM, McKnite AM, Enioutina EY, Sherwin CM, Watt KM, Job KM. Hudson RE, et al. Front Pharmacol. 2023 Mar 23;14:1111601. doi: 10.3389/fphar.2023.1111601. eCollection 2023. Front Pharmacol. 2023. PMID: 37033628 Free PMC article. Review.
What role can decentralized trial designs play to improve rare disease studies?
Moore J, Goodson N, Wicks P, Reites J. Moore J, et al. Orphanet J Rare Dis. 2022 Jun 20;17(1):240. doi: 10.1186/s13023-022-02388-5. Orphanet J Rare Dis. 2022. PMID: 35725484 Free PMC article.
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.
Goodson N, Wicks P, Morgan J, Hashem L, Callinan S, Reites J. Goodson N, et al. NPJ Digit Med. 2022 May 5;5(1):58. doi: 10.1038/s41746-022-00603-y. NPJ Digit Med. 2022. PMID: 35513479 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA

Affiliations

Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDA

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

MeSH terms

LinkOut - more resources

Full Text Sources